{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:19:05Z","timestamp":1787660345473,"version":"build-2736575974"},"reference-count":21,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Neurofibromatosis type 1 (NF1), a rare genetic disorder characterised by neurofibroma growth, affects approximately 25\u2009000 individuals in the UK. Its wide range of clinical manifestations presents significant challenges in providing comprehensive care for patients. In agreement with National Health Service England\u2019s Commissioners, Childhood Tumour Trust initiated a patient-led service evaluation to understand existing care pathways and identify factors influencing patient satisfaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study was coproduced with patient charities, clinicians and the Patient Led Research Hub. Online surveys were composed for patients, families, carers (PFCs) and healthcare professionals (HCPs) and disseminated through charity and healthcare networks. Structured features were analysed using descriptive statistics to review pathways and examine correlations with care satisfaction. Free-text responses were coded and analysed thematically to explore PFCs\u2019 and HPCs\u2019 experiences.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 1083 PFC and 94 HCP responses were received from across the UK (783 and 49 were complete, respectively). Overall, 54% PFCs expressed dissatisfaction with NF1 care. While London had a significantly higher satisfaction rate (64%; p=0.01) than the national average, Scotland (30%, p=0.01) and Northern Ireland (16%, p=0.01) had significantly lower rates. Influencing factors included poor care coordination, long specialist wait times and insufficient signposting to charities. Regarding diagnosis and management, 46 HCP roles, 35 referral routes and 16 sources of management guidelines were identified, indicating a lack of clear pathways and care standardisation. Free-text data revealed additional challenges, including limited education and information for families, low NF1 awareness among professionals, inequitable access to specialists and a desire for holistic care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This evaluation revealed UK-wide dissatisfaction with NF1 care and a pressing need for system-level changes to improve regional disparities and care coordination, enhance patient education and HCP training and establish standardised pathways with a holistic model to enable high-quality equitable care for all NF1 patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjoq-2025-003383","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T13:55:12Z","timestamp":1756389312000},"page":"e003383","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["\u2018Alone on our NF1 island\u2019: a patient-led mixed-method survey study to understand the care pathway for neurofibromatosis type 1 (NF1) patients in the UK"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1365-9803","authenticated-orcid":false,"given":"Shaowen","family":"Ju","sequence":"first","affiliation":[{"name":"University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5598-8592","authenticated-orcid":false,"given":"Laura","family":"Cowley","sequence":"additional","affiliation":[{"name":"University of Cambridge Clinical School, Cambridge, UK"},{"name":"Patient Led Research Hub, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7789-9183","authenticated-orcid":false,"given":"Ishan","family":"Jain","sequence":"additional","affiliation":[{"name":"Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2072-0621","authenticated-orcid":false,"given":"Vanessa","family":"Martin","sequence":"additional","affiliation":[{"name":"Childhood Tumour Trust, East Sussex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2115-4662","authenticated-orcid":false,"given":"Ellie","family":"Day","sequence":"additional","affiliation":[{"name":"Child Health, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7438-5156","authenticated-orcid":false,"given":"Rona","family":"Smith","sequence":"additional","affiliation":[{"name":"Patient Led Research Hub, Cambridge, UK"},{"name":"Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4917-6149","authenticated-orcid":false,"given":"Tessa","family":"Morgan","sequence":"additional","affiliation":[{"name":"University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2025100623451493000_14.3.e003383.1","unstructured":"Nerve Tumours UK . Support for adults with NF1. Available: https:\/\/nervetumours.org.uk\/what-are-nerve-tumours\/what-is-nf1\/support-for-adults-with-nf1 [Accessed 17 Aug 2024]."},{"key":"2025100623451493000_14.3.e003383.2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8"},{"key":"2025100623451493000_14.3.e003383.3","doi-asserted-by":"publisher","DOI":"10.1086\/320121"},{"key":"2025100623451493000_14.3.e003383.4","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100562"},{"key":"2025100623451493000_14.3.e003383.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70063-8"},{"key":"2025100623451493000_14.3.e003383.6","unstructured":"NHS England . Commissioning specialised services. Available: https:\/\/www.england.nhs.uk\/commissioning\/spec-services\/highly-spec-services\/ [Accessed 24 Oct 2024]."},{"key":"2025100623451493000_14.3.e003383.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.045906"},{"key":"2025100623451493000_14.3.e003383.8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12687-015-0247-z","article-title":"Parents\u2019 experiences of caring for a young person with neurofibromatosis type 1 (NF1): a qualitative study","volume":"7","author":"Barke","year":"2016","journal-title":"J Community Genet"},{"key":"2025100623451493000_14.3.e003383.9","doi-asserted-by":"publisher","DOI":"10.4103\/ijnmr.IJNMR_178_20"},{"key":"2025100623451493000_14.3.e003383.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.04.025"},{"key":"2025100623451493000_14.3.e003383.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.08.045"},{"key":"2025100623451493000_14.3.e003383.12","unstructured":"Department of Health and Social Care . The UK rare diseases framework. 2021. Available: https:\/\/assets.publishing.service.gov.uk\/media\/5ff781138fa8f5640335254e\/the-UK-rare-diseases-framework.pdf [Accessed 28 Oct 2024]."},{"key":"2025100623451493000_14.3.e003383.13","unstructured":"Patient Led Research Hub . Available: https:\/\/plrh.org\/ [Accessed 24 Oct 2024]."},{"key":"2025100623451493000_14.3.e003383.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4587","article-title":"Three techniques for integrating data in mixed methods studies","volume":"341","author":"O\u2019Cathain","year":"2010","journal-title":"BMJ"},{"key":"2025100623451493000_14.3.e003383.15","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025100623451493000_14.3.e003383.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7227.114"},{"key":"2025100623451493000_14.3.e003383.17","unstructured":"Nerve Tumours UK . NF1 review guidelines for children. 2023. Available: https:\/\/nervetumours.org.uk\/images\/downloads\/NTUK_0046_NF1_Review_Guidelines_for_Children.pdf [Accessed 27 Oct 2024]."},{"key":"2025100623451493000_14.3.e003383.18","first-page":"45","article-title":"Rare diseases research landscape project report","volume":"3","author":"Bainbridge","year":"2023","journal-title":"NIHR Open Res"},{"key":"2025100623451493000_14.3.e003383.19","unstructured":"Childhood Tumour Trust . Information for health care professionals: NF1 CPD module. United Kingdom Childhood Tumour Trust. Available: https:\/\/www.childhoodtumourtrust.org.uk\/information-for-health-care-professionals\/ [accessed 27 May 2025]"},{"key":"2025100623451493000_14.3.e003383.20","unstructured":"Nerve Tumours UK . The role of the NF specialist advisor. United Kingdom Nerve Tumours UK. Available: https:\/\/nervetumours.org.uk\/images\/downloads\/The_Role_of_the_NF_Specialist_Advisor_v1.pdf [accessed 27 May 2025]"},{"key":"2025100623451493000_14.3.e003383.21","unstructured":"NHS England . NHS standard contract for paediatric neurosciences \u2013 neurodisability: service specification no.E09\/S\/c. London NHS England; 2013. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/06\/e09-paedi-neurodisability.pdf [accessed 27 May 2025]"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2025-003383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T06:45:25Z","timestamp":1759819525000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2025-003383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,28]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjoq-2025-003383"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2025-003383","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}